International Journal of Academic Health and Medical Research (IJAHMR)
  Year: 2023 | Volume: 7 | Issue: 2 | Page No.: 119-130
MULLERIAN DUCT ANOMALIES AND INFERTILITY Download PDF
A.LAHKIM BENNANI, S. ERRARHAY, H. BENNANI, M. BOUBBOU, K. SAOUD, N. MAMOUNI, C. BOUCHIKHI, A.BANANI

Abstract:
Female genital tract congenital anomalies constitute a large group of malformations. Several classifications have been proposed in the past, notably the Musset classification in the French-speaking world, or the AFS classification in the English-speaking world. However, a unification of language has been essential for an accurate diagnosis and a codified and optimal management, this was the objective of the ESHRE/ESGE classification proposed in 2013 classifying female genital tract malformations into uterine (U0 to U6), cervical (C0 to C4) and vaginal (V0 to V4) anomalies. (2) The prevalence of these malformations is often difficult to calculate because of the heterogeneity of the population studied, the divergence of clinical expressions, the multitude of diagnostic tools, and also the different classifications used. However, studies have been done to calculate the prevalence of uterine malformations in the general population and in different subpopulations (infertile women, recurrent miscarriages, etc.). In Morocco, there is no actual study calculating the prevalence in the general population. The clinic is often not very helpful in the diagnosis of uterine malformations, hence the interest in efficient, reliable and least invasive diagnostic tools, which requires the development of hysterosonography in our institutions, as well as 3D ultrasound and MRI, before moving on to hysteroscopy/laparoscopy, which has a diagnostic but above all therapeutic role. The treatment of genital malformations depends essentially on the type of malformation. The bicornuate uterus does not require surgical intervention, in contrast to the septate uterus and cases of vaginal diaphragms, where surgical intervention significantly improves fertility. In our work, the impact on fertility of the treatment of genital tract anomalies has been studied.